NASDAQ: UROYUranium Royalty Corp Stock
$2.34-0.01 (-0.43%)
Updated Apr 17, 2024
UROY Price
$2.34
Fair Value Price
$0.58
Market Cap
$264.73M
52 Week Low
$1.81
52 Week High
$3.76
P/E
53.18x
P/B
1.5x
P/S
11.5x
PEG
N/A
Dividend Yield
N/A
Revenue
$32.60M
Earnings
$4.95M
Gross Margin
28.9%
Operating Margin
12.25%
Profit Margin
15%
Debt to Equity
0
Operating Cash Flow
-$70M
Beta
1.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
UROY Overview
Uranium Royalty Corporation is a pure-play uranium royalty company. The company has royalty interests in the McArthur River, Cigar Lake, Roughrider, Diabase, and Dawn Lake projects in Saskatchewan, Canada, the Anderson and Workman Creek projects in Arizona, the Lance and Reno Creek projects in Wyoming, the Church Rock and Roca Honda projects in New Mexico, the Dewey-Burdock project in South Dakota, the Slick Rock project in Colorado, the Langer Heinrich project in Namibia, and the Michelin project in Newfoundland, Canada. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how UROY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
UROY ($2.34) is overvalued by 302.85% relative to our estimate of its Fair Value price of $0.58 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
UROY ($2.34) is not significantly undervalued (302.85%) relative to our estimate of its Fair Value price of $0.58 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
UROY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
There are 30 more UROY due diligence checks available for Premium users.
Be the first to know about important UROY news, forecast changes, insider trades & much more!
UROY News
Valuation
UROY fair value
Fair Value of UROY stock based on Discounted Cash Flow (DCF)
Price
$2.34
Fair Value
$0.58
Overvalued by
302.85%
UROY ($2.34) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
UROY ($2.34) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
UROY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
53.18x
Industry
1.15x
Market
41.64x
UROY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UROY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
UROY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.5x
Industry
4.44x
UROY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
UROY's financial health
Profit margin
Revenue
$11.3M
Net Income
$2.6M
Profit Margin
23.2%
UROY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$180.1M
Liabilities
$718.7k
Debt to equity
0
UROY's short-term assets ($143.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UROY's short-term assets ($143.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UROY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$56.0M
Investing
$11.7M
Financing
$1.1M
UROY's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
UROY vs Uranium Stocks
Uranium Royalty Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.